Status:
ACTIVE_NOT_RECRUITING
Intratumoral Budding (ITB) in Preoperative Biopsies of Colon and Rectal Cancer
Lead Sponsor:
Insel Gruppe AG, University Hospital Bern
Conditions:
CRC
Eligibility:
All Genders
18+ years
Brief Summary
All the preoperative biopsies of patients suffering colorectal cancer (CRC) will be immunohistochemically stained with a pancytokeratin marker to detect Tumor buds. then, the intratumoral buds (ITB) i...
Eligibility Criteria
Inclusion
- Patients with newly diagnosed stages I and IV colorectal cancer (CRC)
- Age ≥ 18 years
- Written Informed Consent
Exclusion
- No consent
- \< 18 years
Key Trial Info
Start Date :
October 1 2015
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT03336658
Start Date
October 1 2015
End Date
December 31 2024
Last Update
November 13 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of visceral surgery and transplant surgery, Berne University Hospital
Bern, Switzerland, 3010